Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
… RTI-HS. Dr. Galinsky spent 6 years working with myeloma patient organisations generating patient insight and preference data to support regulatory decision-making. She developed and managed large … Care Excellence (NICE), and Food and Drug Administration (FDA), resulting in deeper insights into the ways in which …
… Observational Study of Patient-Reported Quality of Life Utilizing a Novel Mobile … OPPORTUNITY Our client wanted to understand the patient journey and assess patient-reported outcomes of women using their treatment for …
… Na’ngono joined RTI-HS from health informatics specialists First DataBank Europe, where he first worked in a role involving clinical and technical … (regional NHS commissioning groups) across England. In his time at RTI-HS, Na’ngono has undertaken and managed projects …
… benefits, and risks in Europe to support public health and decision making. Collaborative Research Partners CANADA … Disease and Ulcerative Colitis (GETECCU), holds ENEIDA patient register SWEDEN Karolinska Institute UNITED KINGDOM …
Improving Research for Major Depressive Disorder with Quality-of-Life Data Share on: May 18, 2021 Major depressive disorder (MDD) is a leading cause of disability worldwide. Understanding the impact of MDD on quality of life has become increasingly key …
… Real-World Evidence HTA and Reimbursement Submissions Patient-Centered Outcomes Assessment Health Preference …
… literature reviews, type of economic evaluations considered, perspectives used, discounting rates used for …
… on treatment value to support successful reimbursement and patient access. In order to be better prepared for a …
… young adults 16-23 years of age based on shared clinical decision making. Several published studies have demonstrated … revealed differences in vaccination coverage (uptake) over time, based on racial/ethnic background, geographic regions, … around recommendations for shared decision making between patient and provider and barriers related to the …
… diagnosis and regular monitoring, all of which can improve patient outcomes. Biopharma can use these data for research … long-term treatment effects, safety profiles, and patient outcomes beyond controlled clinical environments. … treatments. Application of AI for Efficient Clinical Decision-Making in Oncology There has been a recent push in …